Articles by TJ Chao, MPAS, PA-C

TJ Chao, MPAS, PA-C, examines the case of an 18-year-old female with persistent AD, wherein the patient attributes her flares to her housing conditions. He discusses her treatment plan and addresses the challenges posed by red face syndrome induced by dupilumab, while commenting on how the panel managed patient expectations, treatment preferences, and sustained disease control.

Frontline Forum Part 3: Topical Therapy for Corticosteroid-Responsive Dermatoses
ByNicholas Brownstone, MD,James Q. Del Rosso, DO,Linda Stein Gold, MD,Jayme M. Heim, MSN, FNP-BC,TJ Chao, MPAS, PA-C,Darren West, MPAS, PA-C Experts discuss enhancing patient outcomes, comparing clobetasol cream concentrations, and more.

Frontline Forum Part 2: Topical Therapy for Corticosteroid-Responsive Dermatoses
ByNicholas Brownstone, MD,James Q. Del Rosso, DO,Linda Stein Gold, MD,Jayme M. Heim, MSN, FNP-BC,TJ Chao, MPAS, PA-C,Darren West, MPAS, PA-C Experts discuss enhancing patient outcomes, topical formulations and epidermal barrier dysfunction, and more.

Frontline Forum Part 1: Topical Therapy for Corticosteroid-Responsive Dermatoses
ByNicholas Brownstone, MD,James Q. Del Rosso, DO,Linda Stein Gold, MD,Jayme M. Heim, MSN, FNP-BC,TJ Chao, MPAS, PA-C,Darren West, MPAS, PA-C Experts discuss enhancing patient outcomes, the "mounting mutiny" against topicals, and more.

Experts in dermatology share their insights on how to approach corticosteroid hesitancy in their dermatology patient populations.

Experts in dermatology discuss their considerations for atopic dermatitis and plaque psoriasis topical treatment options highlighting the different penetration, access, and safety considerations.

James Q Del Rosso, DO and TJ Chao, MPAS, PA-C comment on the practical aspects of utilizing topical corticosteroids, including potency, formulation, administration, and utility.

James Q Del Rosso, DO and TJ Chao, MPAS, PA-C discuss the role of topical agents in the management of dermatological conditions reviewing their position and role within the treatment landscape for dermatological conditions.

Experts discuss key takeaways for providers in the management of plaque psoriasis (PP).

Tj Chao, MPAS, and Lauren Miller, MPAS, discuss possible treatment algorithms when using tapinarof for plaque psoriasis (PP) patients.

Lauren Miller, MPAS, and Tj Chao, MPAS, discuss the clinical importance of the remittive effect in plaque psoriasis (PP) patients.

Experts discuss recent studies of novel treatments for plaque psoriasis (PP) and the importance of long-term data.

Tj Chao, MPAS, and Lauren Miller, MPAS, discuss tapinarof as a treatment for plaque psoriasis (PP).

Lauren Miller, MPAS, and Tj Chao, MPAS, discuss new treatments for plaque psoriasis (PP) and their mechanisms of action.

Experts discuss the landscape of topical drugs for plaque psoriasis (PP) and key factors in treatment options.

Tj Chao, MPAS, and Lauren Miller, MPAS, highlight treatment efficacy considerations for plaque psoriasis (PP).

Lauren Miller, MPAS, and Tj Chao, MPAS, discuss how patient goals and education can inform next steps of treatment for plaque psoriasis (PP).

Experts offer insights on treatment selection and patient education for plaque psoriasis (PP).

Lauren Miller, MPAS, and Tj Chao, MPAS, offer considerations for treating pediatric patients with plaque psoriasis (PP).

Experts discuss plaque psoriasis (PP) treatment options for people who are or may become pregnant.

Tj Chao, MPAS, and Lauren Miller, MPAS, highlight comorbidities that caregivers should consider when treating patients with plaque psoriasis (PP).

Lauren Miller, MPAS, and Tj Chao, MPAS, discuss key factors to consider for plaque psoriasis (PP) treatment.

Experts discuss the role and importance of physician assistants in the treatment and care of plaque psoriasis (PP).

Tj Chao, MPAS, and Lauren Miller, MPAS, discuss the symptoms of plaque psoriasis (PP) and why it may be difficult to diagnose.